BRIEF published on 06/06/2025 at 16:03, 1 year 3 months ago Assemblée Générale d'EUROAPI : Approbation des Résolutions et Perspectives Assemblée Générale Perspectives 2023 Résolutions Approuvées EUROAPI R&D Et CDMO
PRESS RELEASE published on 06/06/2025 at 15:58, 1 year 3 months ago Communiqué de presse - AG 2023 L'Assemblée Générale Mixte d'EUROAPI du 11 mai 2023 approuve les comptes de 2022, valide la cooptation d'un nouvel administrateur et confirme les perspectives à court et moyen termes Perspectives Administration Assemblée Générale Mixte EUROAPI Comptes 2022
BRIEF published on 06/04/2025 at 17:50, 1 year 3 months ago EUROAPI nomme Frédéric Robert Directeur commercial pour API et CDMO CDMO Nomination EUROAPI Frédéric Robert API Solutions
BRIEF published on 06/04/2025 at 17:50, 1 year 3 months ago EUROAPI appoints Frédéric Robert as Sales Director for API and CDMO CDMO Appointment EUROAPI Frédéric Robert API Solutions
PRESS RELEASE published on 06/04/2025 at 17:45, 1 year 3 months ago EUROAPI nomme Frédéric Robert au poste de Directeur commercial en charge des activités API Solutions et CDMO EUROAPI nomme Frédéric Robert Directeur commercial pour activités API Solutions et CDMO. Plan de transformation FOCUS-27 et consolidation de sa position de leader européen CDMO Directeur Commercial EUROAPI Frédéric Robert API Solutions
BRIEF published on 03/10/2025 at 15:34, 1 year 6 months ago Goldman Sachs réduit sa participation dans EUROAPI Euronext Paris Franchissement De Seuil Participation Goldman Sachs EUROAPI
BRIEF published on 03/10/2025 at 15:34, 1 year 6 months ago Goldman Sachs reduces its stake in EUROAPI Euronext Paris Participation Goldman Sachs Threshold Crossing EUROAPI
PRESS RELEASE published on 03/10/2025 at 15:29, 1 year 6 months ago Franchissement de seuil Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant EUROAPI, avec cession d'actions et précisions sur la détention indirecte The Goldman Sachs Group Franchissement De Seuils EUROAPI Détention Indirecte Cessions D'actions
BRIEF published on 02/14/2025 at 12:20, 1 year 6 months ago Franchissement de seuil par Goldman Sachs dans EUROAPI Acquisition Franchissement De Seuils Goldman Sachs EUROAPI Actions Et Droits De Vote
BRIEF published on 02/14/2025 at 12:20, 1 year 6 months ago Goldman Sachs Crosses Threshold in EUROAPI Acquisition Goldman Sachs Crossing Thresholds Shares And Voting Rights EUROAPI
Published on 09/12/2026 at 02:35, 11 hours 9 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 44 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 39 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 19 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 44 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 13 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 29 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 33 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 59 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 28 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
